Research News

Immune pathway upregulation and lower genomic instability distinguish EBVpositive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is an aggressive and poorly understood disease that occurs mostly in East Asia. In this collaborative study, led by A/Prof Ng Siok Bian and Dr Jason Pitt, the authors and their team characterise PTCL-EBV as an aggressive lymphoma with minimal genomic instability, immune-related gene expression and activation of NFκB along with its associated genes. These findings afford both novel insight into the pathogenesis of this disease and highlight new potential targets for therapeutic development.

Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335103/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →
Research News

PHF2 regulates genome topology and DNA replication in neural stem cells via cohesion

When a cell divides to make new cells, it needs to copy its DNA so that each new cell has …

Read More →
Research News

METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity

Glioblastoma is the most common and lethal form of adult brain cancer. The presence of cancer stem cells (so-called glioma …

Read More →